AAPC CPC Exam With Confidence Using Practice Dumps

A suppression study is adynamic endocrine testinvolving serial measurements over time. CPT80430represents thesuppression function testitself (the study framework), while the individual lab analytes measured during the test are reported with their specific assay codes based on the test protocol. The scenario includesfive glucose testsandfive human growth hormone (HGH) testsperformed as part of the study. Glucose testing is reported with82947per test, and growth hormone testing is reported with83003per test. Because the stem specifiesfive of each, correct reporting includes80430plus82947 × 5and83003 × 5. Options that report only one unit of 82947/83003 (or reduce the number of tests) fail to reflect the documented serial testing frequency. CPC exam tip: when a dynamic study is described, do not stop at the function test code—also capture theserial analyte measurementswhen the question explicitly provides the number of lab draws/tests. Therefore, the correct coding is80430, 82947 × 5, 83003 × 5.

A tympanoplasty repairs aperforated tympanic membrane. The key phrase “doesnotremove the mastoid” means this istympanoplasty without mastoidectomy, which is correctly represented by69631in the answer set. Codes that include mastoid work (or represent different tympanoplasty variants) are incorrect because the documentation explicitly states the mastoid was not removed. Diagnosis coding should reflect both thechronic otitis mediaand theperforation. In the options,H66.92represents otitis media (as offered) andH72.92represents perforation of the tympanic membrane (as offered). Although the clinical story specifies the left ear, the provided diagnosis options do not include laterality; on CPC-style questions, you choose the best match among the answer choices. Therefore, the correct combination within this question’s choices is69631 with H66.92 and H72.92, matching tympanoplasty without mastoidectomy plus the documented conditions.

For a patient with a mass in the left lower lung suspected to be cancer that is currently documented as a tumor of uncertain behavior, with existing ovarian cancer with metastases to the liver, the ICD-10-CM codes are:

D38.1: Neoplasm of uncertain behavior of bronchus and lung.

C56.9: Malignant neoplasm of unspecified ovary.

C78.7: Secondary malignant neoplasm of liver and intrahepatic bile duct.

D38.1 is used because the behavior of the lung tumor is uncertain, and C56.9 and C78.7 are used to document the known primary and metastatic cancers.

ICD-10-CM guidelines

AMA ' s CPT® Professional Edition (current year)